GcMAF, Nagalase Suppression & Fibrin Reduction: A Therapeutic White Paper

Cancer is not only a disease of uncontrolled proliferation — it is a master of stealth. This white paper outlines the complete blueprint of tumour immune evasion, with a focus on Nagalase-mediated GcMAF suppression, fibrin-based shielding, exosome manipulation, and advanced quantum biofield cloaking. The objective is clear: full-spectrum disruption of cancer’s stealth systems, restoration of immune visibility, and deployment of advanced therapeutic strategies across metabolic, epigenetic, bioelectric, and quantum layers.